3D Fourier Imaging System for High Throughput Analyses of Cancer Organoids

用于癌症类器官高通量分析的 3D 傅里叶成像系统

基本信息

  • 批准号:
    10577796
  • 负责人:
  • 金额:
    $ 19.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-03-01 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

Challenges. Tumor spheroids (and organoids) have become an instrumental tool in cancer research. These self-organized, three-dimensional (3D) systems can recapitulate phenotypic and functional traits of patient tumors in vivo, thereby serving as a powerful testing bed to study tumor heterogeneity, interactions with the environment (e.g., extracellular matrix), and responses to external stimuli (e.g., chemotherapy, radiation). Fully harnessing spheroids' utility, however, is stymied by lack of high-throughput analysis methods. Conventional bright-field microscopy, although widely used to monitor spheroids in culture, fails to capture detailed cellular organizations; advanced fluorescent microscopy can resolve individual cells, but its imaging throughput is restricted by the small field-of-view (FOV) and the scanning mechanisms involved. Innovations. We aim to advance a new volumetric imaging microscope (VIM) for single cell analyses in tumor spheroids. Specifically, we will explore integrating Fourier ptychographic microscopy (FPM) with diffraction tomography. FPM is based on a spatially coded-illumination technique, collecting low resolution image sequences while changing the position of a point-light source. These images are then numerically combined in the Fourier space, which allows FPM to achieve both wide field-of-view and high spatial resolution in 2D images. We reason that full 3D microscopic images can be recovered by accounting for optical diffraction during the numerical reconstruction. Approaches. Aim 1. System development. We will build a VIM system featuring: i) a new numerical algorithm to reconstruct 3D volumetric images; ii) a new light-illumination strategy to speed up the data acquisition; iii) microfluidic cartridges optimized for spheroid culture and drug treatment; and iv) multicolor imaging capacity for molecular detection. The complete VIM will resolve individual cells constituting a spheroid at high resolution (lateral, 0.4 µm; axial, 1 µm) in a large imaging volume. Aim 2. Treatment monitoring with tumor spheroids. We will test VIM's practical utility: VIM-enabled spheroid imaging will reveal earlier than bulk imaging whether a spheroid is responsive or resistance to drug treatment. To generate a tumor model, we will use primary GBM cells from patients. GBM spheroids will be grown and treated with drug (temozolomide) inside microfluidic cartridges. We will use the VIM to monitor how single cells change their phenotypes under treatment, and correlate these changes with treatment outcomes. Impact. The VIM will be a transformative tool for cancer research, empowering researchers with rich data sets and substantially advanced analytics. Immediate applications include better monitoring of anticancer drug responses in 3D cell culture, analyzing cellular heterogeneity, and prospectively detecting cellular fate under various physiological conditions. These outcomes will strengthen the clinical and scientific utility of tumor spheroids in cancer research.
挑战。肿瘤球体(和有机体)已成为癌症研究的工具。这些 自组织三维(3D)系统可以概括患者的表型和功能特征 体内肿瘤,从而成为研究肿瘤异质性的强大试验床,与 环境(如细胞外基质)和对外界刺激(如化疗、放射)的反应。完全 然而,由于缺乏高通量的分析方法,利用球体的效用受到阻碍。传统型 虽然Bright-field显微镜被广泛用于监测培养物中的球体,但它不能捕捉到详细的细胞 组织;先进的fl荧光显微镜可以分辨单个细胞,但其成像吞吐量 受小fi视野(FOV)和扫描机制的限制。创新。我们的目标是 提出了一种用于肿瘤球体单细胞分析的新型体积成像显微镜(VIM)。SPECIfiCALY, 我们将探索将傅里叶层析显微镜(FPM)与衍射层析成像相结合。FPM是基于 在空间编码照明技术上,采集低分辨率图像序列,同时改变 点光源的位置。然后,这些图像在傅里叶空间中进行数值组合,这 允许fi在2D图像中实现宽视野和高空间分辨率。我们认为全3D 在数值重建过程中,通过考虑光学衍射,可以恢复显微图像。 接近了。目标1.系统开发。我们将建立一个具有以下特点的VIM系统:i)一种新的数值算法 重建三维体图像;ii)新的光照策略,以加快数据采集;iii) 针对球体培养和药物治疗进行了优化的MicroflUIDIC墨盒;以及iv)多色成像能力 分子检测。完整的vim将以高分辨率解析构成球体的单个细胞。 (横向,0.4微米;轴向,1微米),成像体积大。目的2.肿瘤球体治疗监测。我们 将测试Vim的实用价值:启用Vim的椭球体成像将比批量成像更早地揭示 球体对药物治疗有反应或耐药。为了生成肿瘤模型,我们将使用原代GBM 来自病人的细胞。基底膜球体将被培养,并在微fl治疗中使用药物(替莫唑胺) 子弹。我们将使用VIM来监测单个细胞如何在治疗下改变其表型,以及 将这些变化与治疗结果相关联。冲击力。VIM将成为治疗癌症的变革性工具 研究,为研究人员提供丰富的数据集和非常先进的分析。立马 应用包括更好地监测3D细胞培养中的抗癌药物反应,分析细胞 异质性,并前瞻性地检测不同生理条件下的细胞命运。这些 结果将加强肿瘤球体在癌症研究中的临床和科学应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hakho Lee其他文献

Hakho Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hakho Lee', 18)}}的其他基金

High-throughput Phenotyping of iPSC-derived Airway Epithelium by Multiscale Machine Learning Microscopy
通过多尺度机器学习显微镜对 iPSC 衍生的气道上皮进行高通量表型分析
  • 批准号:
    10659397
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
3D Fourier Imaging System for High Throughput Analyses of Cancer Organoids
用于癌症类器官高通量分析的 3D 傅里叶成像系统
  • 批准号:
    10358186
  • 财政年份:
    2022
  • 资助金额:
    $ 19.24万
  • 项目类别:
High-throughput Integrated Magneto-electrochemical Exosome (HiMEX) platform to identify neurodevelopmental markers associated with pre and postnatal oxycodone exposure
高通量集成磁电化学外泌体 (HiMEX) 平台,用于识别与产前和产后羟考酮暴露相关的神经发育标志物
  • 批准号:
    10017043
  • 财政年份:
    2019
  • 资助金额:
    $ 19.24万
  • 项目类别:
Clinical platform for high-throughput analyses of extracellular vesicles
细胞外囊泡高通量分析的临床平台
  • 批准号:
    10462501
  • 财政年份:
    2018
  • 资助金额:
    $ 19.24万
  • 项目类别:
Clinical platform for high-throughput analyses of extracellular vesicles
细胞外囊泡高通量分析的临床平台
  • 批准号:
    9754806
  • 财政年份:
    2018
  • 资助金额:
    $ 19.24万
  • 项目类别:
Clinical platform for high-throughput analyses of extracellular vesicles
细胞外囊泡高通量分析的临床平台
  • 批准号:
    10224771
  • 财政年份:
    2018
  • 资助金额:
    $ 19.24万
  • 项目类别:
Clinical platform for high-throughput analyses of extracellular vesicles
细胞外囊泡高通量分析的临床平台
  • 批准号:
    9906460
  • 财政年份:
    2018
  • 资助金额:
    $ 19.24万
  • 项目类别:
Multiplexed exosome analyses with DNA barcoding
使用 DNA 条形码进行多重外泌体分析
  • 批准号:
    9266748
  • 财政年份:
    2016
  • 资助金额:
    $ 19.24万
  • 项目类别:
Multiplexed exosome analyses with DNA barcoding
使用 DNA 条形码进行多重外泌体分析
  • 批准号:
    9099367
  • 财政年份:
    2016
  • 资助金额:
    $ 19.24万
  • 项目类别:
MAGNETIC NANOSENSORS FOR BIOMEDICAL ANALYSES OF MICROVESICLES
用于微泡生物医学分析的磁性纳米传感器
  • 批准号:
    8458935
  • 财政年份:
    2012
  • 资助金额:
    $ 19.24万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Standard Grant
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 19.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了